Novel Anti-inflammatory Mechanism of Elafin
18-Dec-2006
Original publication: Butler MW, Robertson I, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG.; "Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway."; J Biol Chem. 2006; 281: 34730-5.
Most read news
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
First Chinese Patent for pSivida Limited
Go to page
Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Phase II Clinical Trial for New Obesity Drug
Go to page
BASF Plant Science takes Amflora case to EU Court - BASF filed action against the EU Commission for failure to act
Go to page